- Telehealth visits
Ana Grijalvo-Perez, MD
Pediatric Neurology- Telehealth visits
On this page
About me
Dr. Ana Grijalvo Perez is a pediatric neurologist who cares for children with movement and other neurological disorders. Her areas of special interest include pediatric movement disorders, such as Tourette syndrome, dystonia, myoclonus, spasticity, paroxysmal movement disorders, tremors and chorea. She is also interested in pediatric epilepsy, neurodevelopmental disorders, autism spectrum disorder and migraines.
Grijalvo Perez received her medical degree from the Universidad Autónoma de Madrid School of Medicine and completed a residency in pediatrics at Rady Children's Hospital – San Diego. She completed a fellowship in child neurology at the University of California, San Diego. She speaks Spanish, Italian and German.
Education & training
Board certification
- Neurology with Special Qualification in Child Neurology, American Board of Psychiatry and Neurology
Fellowship
- Neurology, University of California Medical Center San Diego
Residency
- Pediatrics, Rady Childrens Hospital GME - UCSD
Internship
- Pediatrics, Rady Childrens Hospital GME - UCSD
Degree
- MD, Autonomous University School of Medicine
- MD, Universidad Autonoma de Madrid
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222384%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222384%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.